T1	Participants 88 129	patients with inflammatory bowel disease.
T2	Participants 368 389	Fifty-six outpatients
T3	Participants 941 981	Thirty-nine subjects completed the study
T4	Participants 1385 1414	CONCLUSIONS Findings indicate
